Ventricular Tachycardia: Clinical Trials

10 trials for Ventricular Tachycardia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 recruiting, 1 withdrawn. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 4, Unknown 3, Recruiting 2, Withdrawn 1
Phase 21Completed 1

Follow Ventricular Tachycardia: new trials by email Literature Review of Ventricular Tachycardia trials Research Report on Ventricular Tachycardia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Dexmedetomidine, Normal saline - Ventricular Tachycardia, Ventricular Arrhythmias
Phase 3RecruitingOttawa Heart Institute Research Corporation1922024-05-082026-07-07
Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Control - Catheter Ablation for VT, Treatment - Non-Invasive Radio Ablation for VT - Ventricular Tachycardia
Phase 3RecruitingOttawa Heart Institute Research Corporation2442022-12-062026-09-30
GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial)
Left ganglion stellate block, Sham left ganglion stellate block - Ventricular Arrythmia, Ventricular Tachycardia
Phase 3UnknownInstitute for Clinical and Experimental Medicine802021-08-212021-10-19
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
Cardiac Sympathetic Denervation (CSD), Routine Care - Sudden Cardiac Death, Ventricular Tachycardia
Phase 3UnknownUniversity of California, Los Angeles402021-07-262024-01-19
Preventive VT Substrate Ablation in Ischemic Heart Disease
Ventricular tachycardia substrate-based radiofrequency ablation - Ventricular Tachycardia, Ventricular Arrythmia
Phase 3UnknownCentro Medico Teknon582021-06-012023-08-30
A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.
Dantrolene/Ryanodex, Placebo - Ventricular Tachycardia
Phase 2 / Phase 3CompletedVanderbilt University Medical Center682020-08-212026-10-08
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Ethanol, Ablation - Ventricular Tachycardia, Atrial Fibrillation
Phase 3CompletedThe Methodist Hospital Research Institute3432013-10-012025-08-21
Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia
Catheter Ablation, Medical therapy (sotalol or amiodarone) - Ventricular Tachycardia, Coronary Artery Disease
Phase 3WithdrawnNewmarket Electrophysiology Research Group Inc2013-04-012015-01-27
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
Radiofrequency Catheter Ablation (RFCA) - Ventricular Tachycardia
Phase 3CompletedTexas Cardiac Arrhythmia Research Foundation1202010-01-012014-08-25
Exercise Training in ICD Recipients; Effect on Therapy Delivered, Depression and Anxiety
Exercise training - Ventricular Tachycardia
Phase 3CompletedHelse Stavanger HF402008-04-012016-08-25

Narrower conditions

Tachycardia, Ventricular (10)  ·  Ventricular Fibrillation (3)  ·  Atrial Fibrillation (2)  ·  Death, Sudden, Cardiac (2)  ·  Myocardial Ischemia (2)  ·  Arrhythmias, Cardiac (1)  ·  Bites and Stings (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Heart Diseases (1)  ·  Myocardial Infarction (1)  ·  Pathologic Processes (1)

Broader conditions

Cardiac Conduction System Disease (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Tachycardia (10)  ·  Arrhythmias, Cardiac (9)  ·  Cardiovascular Diseases (9)  ·  Heart Diseases (9)  ·  Pathologic Processes (9)  ·  Death (2)  ·  Death, Sudden (2)  ·  Heart Arrest (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Chemically-Induced Disorders (1)  ·  Coronary Disease (1)

Interventions

Catheter Ablation (2)  ·  Amiodarone (1)  ·  Dantrolene (1)  ·  Dexmedetomidine (1)  ·  Ethanol (1)  ·  Exercise (1)  ·  Saline Solution (1)  ·  Sotalol (1)

Sponsors

Ottawa Heart Institute Research Corporation (2)  ·  Centro Medico Teknon (1)  ·  Helse Stavanger HF (1)  ·  Institute for Clinical and Experimental Medicine (1)  ·  Newmarket Electrophysiology Research Group Inc (1)  ·  Texas Cardiac Arrhythmia Research Foundation (1)  ·  The Methodist Hospital Research Institute (1)  ·  University of California, Los Angeles (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (5)  ·  Canada (2)  ·  Czechia (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Alf Inge Larsen, MD, PhD (1)  ·  Andrea Natale, MD FACC FHRS (1)  ·  Antonio Berruezo, MD, PhD (1)  ·  Calum Redpath (1)  ·  Marmar Vaseghi, MD, PhD (1)  ·  Miguel Valderrabano, MD (1)  ·  William Stevenson, MD (1)  ·  Yaariv Khaykin, MD (1)

Results publications

PMID 26718674, PMID 33107945, PMID 36227461, PMID 40894163, PMID 41592634

NIH funding

R01HL115003 (1)